Community Engagement for Systemic Racism
(AACS Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment AA Communities Speak for addressing systemic racism?
The Presence 5 for Racial Justice (P5RJ) study shows that improving communication between healthcare providers and Black patients can help address racism in healthcare. This approach, which includes listening carefully and acknowledging socio-political factors, may support the goals of AA Communities Speak by fostering trust and empowerment in Black communities.12345
How does the treatment in the Community Engagement for Systemic Racism trial differ from other treatments for systemic racism?
This treatment is unique because it focuses on creating safe dialogues between people of different races to address systemic racism, unlike traditional approaches that may not emphasize direct communication and shared learning. It involves engaging individuals in discussions to examine unconscious biases and promote awareness, aiming for systemic change through education and reflection.678910
What is the purpose of this trial?
African Americans are less likely to receive quality end-of-life (EoL) care. Addressing disparities in EoL care will need efforts to support a better understanding of African American patients' EoL cultural values and preferences for EoL communication and the impact of historical and ongoing care delivery inequities in healthcare settings.Our proposed "Caring for Older African Americans" training program is designed to empower clinicians to improve goal-concordant EoL care delivery by using community-developed storytelling videos to create empathy with experiences of racism in EoL care, guidelines for culturally concordant EoL care delivery, and an implicit bias recognition and management training to mitigate bias in goals of care communication.
Research Team
Jennifer Tjia, MD, MSCE
Principal Investigator
University of Massachusetts, Worcester
Eligibility Criteria
This trial is for African American individuals aged 60 or older, who are non-Hispanic/Latino and speak English. It includes those with serious illnesses like cancer or heart disease, bereaved family members of such patients, and pastors. Participants must have a certain level of cognitive function (Callahan score ≥4) and be able to complete surveys.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-intervention (Control)
Clinician clusters undergo a pre-intervention period before the training program begins
Intervention
Clinicians receive the African American Communities Speak (AACS) Education Intervention, including training on culturally concordant care and implicit bias management
Post-intervention (Exposure)
Clinician clusters undergo a post-intervention period to assess the impact of the training program
Follow-up
Participants are monitored for the effectiveness of the intervention on therapeutic alliance and goal-concordant care
Treatment Details
Interventions
- AA Communities Speak
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
Montefiore Medical Center
Collaborator
University of California, San Francisco
Collaborator
University of Massachusetts, Worcester
Collaborator